Molecular Biomarkers of Response to Radiation Therapy in Breast Cancer

Recruiting now

Conditions studied: Breast Cancer, Radiotherapy Side Effect

In brief

The purpose of this study is to identify potential genetic and other molecular biomarkers of response to radiation therapy in breast cancer that may help to personalize breast cancer radiation treatment in the future.

Key facts

Study ID

NCT06648148

Run by

Institute of Oncology Ljubljana

People needed

200

Starts

2019-11-01

Expected to finish

2029-12-31

Last updated by the study team

2024-10-18

Who can join

Age: 18 and older, up to 75. Sex: female. Healthy volunteers: not accepted.

You may qualify if…

• Breast cancer patients with DCIS with an indication for adjuvant radiation therapy

You may not qualify if…

• Any specific systemic oncological therapy

Where it is running

• Institute of Oncology Ljubljana — Ljubljana, Slovenia (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.